Spots Global Cancer Trial Database for paclitaxel injection
Every month we try and update this database with for paclitaxel injection cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Study of RC48-ADC in Local Advanced or Metastatic Gastric Cancer With the HER2-Overexpression | NCT04714190 | Gastric Cancer HER2 Overexpres... | RC48-ADC Paclitaxel inje... Irinotecan Hydr... Apatinib Mesyla... | 18 Years - | RemeGen Co., Ltd. | |
| Paclitaxel Micelles for Injection / Paclitaxel Injection in Combination With Cisplatin for First-line Therapy of Advanced NSCLC | NCT02667743 | Non-Small Cell ... | Paclitaxel Mice... Paclitaxel Inje... Cisplatin | 18 Years - 70 Years | Shanghai Yizhong Pharmaceutical Co., Ltd. | |
| Oral Paclitaxel Trial In Recurrent and Metastatic Breast Cancer As 1st Line Therapy | NCT03315364 | Recurrent or Me... | Oral paclitaxel Paclitaxel inje... | 19 Years - | Daehwa Pharmaceutical Co., Ltd. | |
| A Clinical Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsules Versus Paclitaxel as Weekly Treatment of Relapsed Platinum-resistant Ovarian Cancer | NCT05145218 | Recurrent Plati... | Anlotinib Hydro... Paclitaxel inje... TQB2450 injecti... | 18 Years - 75 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| Carrelizumab Combined With Concurrent Radiotherapy and Chemotherapy for Unresectable Esophageal Squamous Cell Carcinoma | NCT06048926 | Esophageal Squa... | Carrelizumab Paclitaxel inje... Cisplatin Concurrent chem... | 18 Years - 75 Years | The First Affiliated Hospital with Nanjing Medical University | |
| Assessing ImmunoResponse Post Eribulin: Eribulin and Immunogenicity in Advanced Breast Cancer | NCT05033769 | Breast Cancer F... Neoplasm, Breas... Breast Cancer M... | Eribulin Inject... Paclitaxel inje... | 18 Years - | Institut fuer Frauengesundheit | |
| A Study of Anlotinib Hydrochloride Capsule Combined With AK105 Injection in Subject With Advanced Gastric and Gastro-oesophageal Junction Adenocarcinoma | NCT04385550 | Advanced Gastri... | Anlotinib hydro... AK105 injection Paclitaxel inje... Docetaxel injec... | 18 Years - 75 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| Carrelizumab Combined With Concurrent Radiotherapy and Chemotherapy for Unresectable Esophageal Squamous Cell Carcinoma | NCT06048926 | Esophageal Squa... | Carrelizumab Paclitaxel inje... Cisplatin Concurrent chem... | 18 Years - 75 Years | The First Affiliated Hospital with Nanjing Medical University | |
| A Study of RC48-ADC in Local Advanced or Metastatic Gastric Cancer With the HER2-Overexpression | NCT04714190 | Gastric Cancer HER2 Overexpres... | RC48-ADC Paclitaxel inje... Irinotecan Hydr... Apatinib Mesyla... | 18 Years - | RemeGen Co., Ltd. | |
| A Clinical Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsules Versus Paclitaxel as Weekly Treatment of Relapsed Platinum-resistant Ovarian Cancer | NCT05145218 | Recurrent Plati... | Anlotinib Hydro... Paclitaxel inje... TQB2450 injecti... | 18 Years - 75 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| Assessing ImmunoResponse Post Eribulin: Eribulin and Immunogenicity in Advanced Breast Cancer | NCT05033769 | Breast Cancer F... Neoplasm, Breas... Breast Cancer M... | Eribulin Inject... Paclitaxel inje... | 18 Years - | Institut fuer Frauengesundheit | |
| Study of Paclitaxel Micelles for Injection in Chinese Patients With Advanced Solid Tumors. | NCT04778839 | Advanced Solid ... | Paclitaxel Mice... Paclitaxel inje... | 18 Years - 70 Years | First Affiliated Hospital of Zhejiang University | |
| Efficacy and Safety of TQB2450 Injection Combined With Chemotherapy ± Anlotinib Hydrochloride Capsules for Advanced Endometrial Cancer or Sarcoma of Uterus. | NCT05481645 | Advanced Endome... Sarcoma of Uter... | TQB2450 injecti... Anlotinib Hydro... Carboplatin Inj... Paclitaxel Inje... Doxorubicin Hyd... Gemcitabine Hyd... Docetaxel injec... | 18 Years - | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| Study of Paclitaxel Micelles for Injection in Chinese Patients With Advanced Solid Tumors. | NCT04778839 | Advanced Solid ... | Paclitaxel Mice... Paclitaxel inje... | 18 Years - 70 Years | First Affiliated Hospital of Zhejiang University | |
| Camrelizumab Combined With Apatinib Mesylate or Camrelizumab Alone for First-line Treatment in Subjects With Programmed Death Ligand 1 (PD-L1) Positive Relapsed or Advanced Non-small Cell Lung Cancer (NSCLC) | NCT04203485 | PD-L1 Positive ... | Camrelizumab 20... Apatinib Mesyla... Pemetrexed diso... Paclitaxel inje... Carboplatin | 18 Years - 70 Years | Jiangsu HengRui Medicine Co., Ltd. | |
| Recombinant Human Endostatin Adenovirus Combined With Chemotherapy for Advanced Head and Neck Malignant Tumors | NCT02283489 | Head and Neck N... | recombinant hum... Cisplatin injec... Paclitaxel inje... | 18 Years - 70 Years | Chengdu Shi Endor Biological Engineering Technology Co., Ltd | |
| A Study of MRG002 Versus Investigator's Choice of Chemotherapy in the Treatment of Patients With HER2-positive Unresectable Advanced or Metastatic Urothelial Cancer | NCT05754853 | Advanced or Met... | MRG002 Docetaxel Injec... Paclitaxel Inje... Gemcitabine Hyd... Pemetrexed Diso... | 18 Years - 75 Years | Shanghai Miracogen Inc. | |
| Study of Paclitaxel Micelles for Injection in Chinese Patients With Advanced Solid Tumors. | NCT04778839 | Advanced Solid ... | Paclitaxel Mice... Paclitaxel inje... | 18 Years - 70 Years | First Affiliated Hospital of Zhejiang University | |
| Assessing ImmunoResponse Post Eribulin: Eribulin and Immunogenicity in Advanced Breast Cancer | NCT05033769 | Breast Cancer F... Neoplasm, Breas... Breast Cancer M... | Eribulin Inject... Paclitaxel inje... | 18 Years - | Institut fuer Frauengesundheit | |
| Efficacy and Safety of TQB2450 Injection Combined With Chemotherapy ± Anlotinib Hydrochloride Capsules for Advanced Endometrial Cancer or Sarcoma of Uterus. | NCT05481645 | Advanced Endome... Sarcoma of Uter... | TQB2450 injecti... Anlotinib Hydro... Carboplatin Inj... Paclitaxel Inje... Doxorubicin Hyd... Gemcitabine Hyd... Docetaxel injec... | 18 Years - | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| Recombinant Human Endostatin Adenovirus Combined With Chemotherapy for Advanced Head and Neck Malignant Tumors | NCT02283489 | Head and Neck N... | recombinant hum... Cisplatin injec... Paclitaxel inje... | 18 Years - 70 Years | Chengdu Shi Endor Biological Engineering Technology Co., Ltd | |
| Tislelizumab Combined With Chemotherapy in the Cross-line Treatment of First-line Resistant Advanced Gastric Cancer | NCT05751265 | Gastric Cancer | Tislelizumab 5Fu Paclitaxel inje... | 18 Years - 75 Years | Fujian Cancer Hospital | |
| DV Combined With Cadonilimab in Subjects With HER2-expressing Gastric Cancer and Gastroesophageal Junction Adenocarcinoma After Progression on First-line Therapy | NCT06221748 | Gastric Cancer Gastroesophagea... | Disitamab Vedot... Cadonilimab Inj... Paclitaxel Inje... | 18 Years - 75 Years | RemeGen Co., Ltd. | |
| Endocrine Therapy With Abemaciclib or Chemotherapy as Initial Metastatic Treatment in ER+/HER2- Breast Cancer | NCT04158362 | Cancer Metastat... | Paclitaxel inje... Capecitabine ta... Letrozole 2.5mg Anastrozole 1mg Fulvestrant Pre... Abemaciclib | 18 Years - | UNICANCER | |
| Dose Escalation and Pharmacokinetic Study of Paclitaxel Liposome Injection in Treating Patients With Advanced Solid Tumor After Failure From Conventional Treatments | NCT01994031 | Solid Tumors | Paclitaxel lipo... Paclitaxel inje... | 18 Years - 75 Years | Nanjing Luye Sike Pharmaceutical Co., Ltd. | |
| A Study of LVGN6051 Combination Therapy in Patient With Head and Neck Squamous Cell Carcinoma (HNSCC) | NCT06378177 | Head and Neck S... | LVGN6051 Monocl... toripalimab Inj... Paclitaxel inje... | 18 Years - | Lyvgen Biopharma Holdings Limited |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
